miR-107 inhibits CDK6 expression, differentiation, and lipid storage in human adipocytes.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
05 01 2019
Historique:
received: 06 07 2018
revised: 03 09 2018
accepted: 22 09 2018
pubmed: 28 9 2018
medline: 16 5 2019
entrez: 28 9 2018
Statut: ppublish

Résumé

MicroRNA-107 (miR-107) plays a regulatory role in obesity and insulin resistance, but the mechanisms of its function in adipocytes have not been elucidated in detail. Here we show that overexpression of miR-107 in pre- and mature human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes attenuates differentiation and lipid accumulation. Our results suggest that miR-107 controls adipocyte differentiation via CDK6 and Notch signaling. CDK6 is a validated target of miR-107 and was downregulated upon miR-107 overexpression. Notch3, a signaling receptor involved in adipocyte differentiation, has been shown to decrease upon CDK6 depletion; Here Notch3 and its target Hes1 were downregulated by miR-107 overexpression. In mature adipocytes, miR-107 induces a triglyceride storage defect by impairing glucose uptake and triglyceride synthesis. To conclude, our data suggests that miR-107 has distinct functional roles in preadipocytes and mature adipocytes; Its elevated expression at these different stages of adipocytes may on one hand dampen adipogenesis, and on the other, promote ectopic fatty acid accumulation and reduced glucose tolerance.

Identifiants

pubmed: 30261211
pii: S0303-7207(18)30275-2
doi: 10.1016/j.mce.2018.09.007
pii:
doi:

Substances chimiques

MIRN107 microRNA, human 0
MicroRNAs 0
Receptors, Notch 0
Transcription Factor HES-1 0
Triglycerides 0
HES1 protein, human 149348-15-2
CDK6 protein, human EC 2.7.11.22
Cyclin-Dependent Kinase 6 EC 2.7.11.22
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-116

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Maria A Ahonen (MA)

Minerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland.

P A Nidhina Haridas (PAN)

Minerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland.

Raghavendra Mysore (R)

Minerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland.

Martin Wabitsch (M)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

Pamela Fischer-Posovszky (P)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

Vesa M Olkkonen (VM)

Minerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland; Department of Anatomy, Faculty of Medicine, University of Helsinki, Finland. Electronic address: vesa.olkkonen@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH